Negative regulation of cannabinoid receptor 2‑induced tumorigenic effect by sphingosine‑1‑phosphate receptor 5 activation.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8874
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2025 AND VI 53 AND IP 3
Results: 10
1
2
Cysteine‑ and glycine‑rich protein 2: A vital regulator that inhibits necroptosis glioma cell by activating the JAK‑STAT1 pathways.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8873
- By:
- Publication type:
- Article
3
Role of miRNA‑145‑5p in cancer (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8872
- By:
- Publication type:
- Article
4
Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8871
- By:
- Publication type:
- Article
5
[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8870
- By:
- Publication type:
- Article
6
Protein regulator of cytokinesis 1 regulates autophagy in hepatitis B virus‑associated liver cancer development.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8869
- By:
- Publication type:
- Article
7
Role of long noncoding RNAs in the regulation of epithelial‑mesenchymal transition in osteosarcoma (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8868
- By:
- Publication type:
- Article
8
Triple‑negative breast cancer cell‑derived piR‑31115 promotes the proliferation and migration of endothelial cells via METTL3‑mediated m6A modification of YAP1.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8867
- By:
- Publication type:
- Article
9
[Retracted] Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8866
- By:
- Publication type:
- Article
10
Heteronemin suppresses EGF‑induced proliferation through the PI3K/PD‑L1 signaling pathways in cholangiocarcinoma.
- Published in:
- Oncology Reports, 2025, v. 53, n. 3, p. N.PAG, doi. 10.3892/or.2025.8865
- By:
- Publication type:
- Article